TickerFactsScreenerDevelopers

Estrella Immunopharma, Inc. (ESLAW) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2021: $478.9K2022: $40.8K2023: $2.48M2024: $916.9K2025: $1.38M$1.38M
2021Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$1.38M+51.0%
2024$916.9K-63.0%
2023$2.48M+5976.0%
2022$40.8K-91.5%
2021$478.9K—